Erratum: Association between body mass index and prognosis of colorectal cancer: A meta-analysis of prospective cohort studies (PLoS ONE (2015) 10:3 (e0120706) DOI: 10.1371/journal.pone.0120706);Association between body mass index and prognosis of colorectal cancer: A meta-analysis of prospective cohort studies

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Lee, Junga ^a   Meyerhardt, Jeffrey A ^b   Giovannucci, Edward ^c   Jeon, Justin Y ^a  

^a Yonsei University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SEX DIFFERENCE; UNDERWEIGHT; COLORECTAL NEOPLASMS; META ANALYSIS; MORTALITY; ODDS RATIO; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY;

BODY MASS INDEX; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MORTALITY; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84926317315     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147456     Document Type: Erratum

References (39)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917. doi: 10.1002/ijc.25516 PMID: 21351269
2. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1-e34. doi: 10.1016/j.jclinepi.2009.06.006 PMID: 19631507
3. Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, et al. (2009) Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 11: 547-563. doi: 10.1111/j.1463-1318.2009.01766.x PMID: 19207714
4. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Tugwell P (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Presented at the 3rd Symposium on Systematic Reviews Beyond the Basics, July 3-5, 2000, Oxford, UK.
5. Okabayashi K, Ashrafian H, Hasegawa H, Yoo JH, Patel VM, Harling L, et al. (2012) Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 107: 1175-1185; quiz 1186. doi: 10.1038/ajg.2012.180 PMID: 22733302
6. Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, et al. (2013) Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 8: e53916. doi: 10.1371/journal.pone.0053916 PMID: 23349764
7. Baade PD, Meng X, Youl PH, Aitken JF, Dunn J, Chambers SK (2011) The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia. Cancer Epidemiol Biomarkers Prev 20: 1410-1420. doi: 10.1158/1055-9965.EPI-11-0079 PMID: 21558496
8. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, et al. (2004) Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 22: 648-657. PMID: 14966087
9. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Nelson H, et al. (2008) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26: 4109-4115. doi: 10.1200/JCO.2007.15.6687 PMID: 18757324
10. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS, et al. (2003) Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98: 484-495. PMID: 12879464
11. Kuiper JG, Phipps AI, Neuhouser ML, Chlebowski RT, Thomson CA, Irwin ML, et al. (2012) Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 23: 1939-1948. doi: 10.1007/s10552-012-0071-2 PMID: 23053793
12. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, et al. (2006) Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98: 1647-1654. PMID: 17105987
13. Sinicrope FA, Foster NR, Yothers G, Benson A, Seitz JF, Labianca R, et al. (2013) Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 119: 1528-1536. doi: 10.1002/cncr.27938 PMID: 23310947
14. Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97: 1679-1687. PMID: 16288121
15. Prizment AE, Flood A, Anderson KE, Folsom AR (2010) Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 19: 2229-2237. doi: 10.1158/1055-9965.EPI-10-0522 PMID: 20826830
16. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM (2012) Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30: 42-52. doi: 10.1200/JCO.2011.38.0287 PMID: 22124093
17. Chin CC, Kuo YH, Yeh CY, Chen JS, Tang R, Changchien C-R, et al. (2012) Role of body mass index in colon cancer patients in Taiwan. World J Gastroenterol 18: 4191-4198. doi: 10.3748/wjg.v18.i31.4191 PMID: 22919253
18. Pelser C, Arem H, Pfeiffer RM, Elena JW, Alfano CM, Hollenbeck AR, et al. (2014) Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH)-AARP Diet and Health Study. Cancer. 120 (10):1540-1547. doi: 10.1002/cncr.28573 PMID: 24591061
19. Fedirko V, Romieu I, Aleksandrova K, Pischon T, Trichopoulos D, Pischon T, et al. (2014) Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations. Int J Cancer 135: 1949-1960. doi: 10.1002/ijc.28841 PMID: 24623514
20. Boyle T, Fritschi L, Platell C, Heyworth J (2013) Lifestyle factors associated with survival after colorectal cancer diagnosis. Br J Cancer 109: 814-822. doi: 10.1038/bjc.2013.310 PMID: 23787918
21. Schlesinger S, Siegert S, Koch M, Walter J, Heits N, Hinz S, et al. (2014) Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis. Cancer Causes Control 25: 1407-1418. doi: 10.1007/s10552-014-0435-x PMID: 25037235
22. Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A (2006) Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control 17: 63-70. PMID: 16411054
23. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C (2010) Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res 16: 1884-1893. doi: 10.1158/1078-0432.CCR-09-2636 PMID: 20215553
24. Sairenchi T, Iso H, Irie F, Fukasawa N, Ota H, Muto T (2008) Underweight as a predictor of diabetes in older adults: a large cohort study. Diabetes Care 31:583-4. PMID: 18071003
25. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LAM, Skali H, et al. (2007) Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116:627-36. PMID: 17638930
26. Renehan AG, Roberts DL, Dive C (2008) Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114: 71-83. doi: 10.1080/13813450801954303 PMID: 18465361
27. Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17: 328-336. PMID: 16956771
28. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, et al. (2004) Obesity and colon cancer: does leptin provide a link? Int J Cancer 109: 149-152. PMID: 14735482
29. Fasshauer M, Paschke R (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46: 1594-1603. PMID: 14605806
30. Chung YW, Han DS, Park YK, Son BK, Paik CH, Lee HL, et al. (2006) Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 38: 668-672. PMID: 16790371
31. Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, et al. (2009) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27: 176-185.
32. Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, XiongW(2012) Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One 7:e43892. doi: 10.1371/journal.pone.0043892 PMID: 22937118
33. Jeon JY, Jeong DH, Park MG, Lee J-W, Chu SH, Park J-H, et al. (2013) Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer. PLoS One 8:e55196. doi: 10.1371/journal.pone.0055196 PMID: 23405123
34. Palta M, Prineas RJ, Berman R, Hannan P (1982) Comparison of self-reported and measured height and weight. Am J Epidemiol 115: 223-230. PMID: 7058781
35. Parkin E, O'Reilly DA, Sherlock DJ, Manoharan P, Renehan AG (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev 15: 434-451. doi: 10.1111/obr.12140 PMID: 24433336
36. Li P, Wu H, Zhang H, Shi Y, Xu J, Ye Y, et al. (2014) Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut. doi: 10.1136/gutjnl-2014-308260
37. Zhu B, Zou L, Qi L, Zhong R, Miao X (2014) Allium Vegetables and Garlic Supplements Do Not Reduce Risk of Colorectal Cancer, Based on Meta-analysis of Prospective Studies. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 12 (12):1991-2001 e1994. doi: 10.1016/j.cgh.2014.03.019 PMID: 24681077
38. Morikawa T, Kuchiba A, Yamauchi M, Meyerhardt JA, Shima K, Nosho K, et al (2011) Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. Jama 305 (16):1685-1694. doi: 10.1001/jama.2011.513 PMID: 21521850
39. Morikawa T, Kuchiba A, Lochhead P, Nishihara R, Yamauchi M, Imamura Y, et al. (2013) Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with beta-catenin (CTNNB1) status. Cancer research 73 (5):1600-1610. doi: 10.1158/0008-5472.CAN-12-2276 PMID: 23442321